pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3915 |
Genomic Coordinates | chrX: 32583656 - 32583752 |
Description | Homo sapiens miR-3915 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3915 | |||||||||||||||
Sequence | 21| UUGAGGAAAAGAUGGUCUUAUU |42 | |||||||||||||||
Evidence | Experimental | |||||||||||||||
Experiments | Illumina | |||||||||||||||
SNPs in miRNA |
|
|||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TXLNA | ||||||||||||||||||||
Synonyms | IL14, TXLN | ||||||||||||||||||||
Description | taxilin alpha | ||||||||||||||||||||
Transcript | NM_175852 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TXLNA | |||||||||||||||||||||
3'UTR of TXLNA (miRNA target sites are highlighted) |
>TXLNA|NM_175852|3'UTR 1 AGAGCCTGGTGTTGGGTCATGCTGGGAAGGGAGCGGCAGCCCAGCCAGGCCTGGCCCATAAAAGGCTCCCATGCTGAGCA 81 GCCCATTGCTGAAGCCAGGATGTTCTGACCTGGCTGGCATCTGGCACTTGCAATTTTGGATTTTGTGGGTCAGTTTTACG 161 TACATAGGGCATTTTGCAAGGCCTTGCAAATGCATTTATACCTGTAAGTGTACAGTGGGCTTGCATTGGGGATGGGGGTG 241 TGTACAGATGAAGTCAGTGGCTTGTCTGTGAGCTGAAGAGTCTTGAGAGGGGCTGTCATCTGTAGCTGCCATCACAGTGA 321 GTTGGCAGAAGTGACTTGAGCATTTCTCTGTCTGATTTGAGGCTCAGACCCCTCCCTGCCCTTCAGAGCTCAAGACAAGT 401 AATACACCCAGGTCTTGACTGCATTTGTCTTGTGAGCAGGGCTTGCTTGGTCAGCTCAGGCCCTCCTAGCTGCTCTGGAG 481 GCTCCTTTGATTCTCTAGACCTGGAAAAGGTGTCCCTAGGCAGAGCCCTGGCAGGGCGCTCAGAGCTGGGGATTTCCTGC 561 CTGGAACAAGGGACCTGGAGAATGTTTTTGCGTGGGATGATGTGCTGGTCAGGAGCCCCTTGGGCATCGCTTCCCCTGCC 641 CTTTGGTAGTGCCAGGACCAGGCCAATGATGCTTCTCAGTAGCCTTATCATTCACAGGTGCCTCTCTAGCCTGCACAAAT 721 GATTGACAAGAGATCACCCAAAGGATTATTTCTGAAGGTGTTTTTTTCTTTATTTCTTTTTCTTTTTTTTTTTTTTTCTT 801 TTTCTTTTTTTTTTGCACATGACAGTGTTTGTATTGAGGACCTTCCAAGGAAGAGGGATGCTGTAGCAGTGGTGCCTGGG 881 TGCCTGGCCTCCAGTGTCCCACCTCCTTCACCACCCCACTTGGCTCCTTTGCCATCTTGATGCTGAGGTTTCCTGTTTGG 961 TGAGATCAGGTTGTTTGTGGTAAAAGAAAGGAAAGGGCTTCTGATGGCTTTGCCACAAGCTTACCTGTGGGTTTCAGTCC 1041 TGAGAGGCCACCACCAGTTCCCATCAGCACTGTCTCCATGCAGCAGTTGCTGGGTCCCATGTCCAGCTGCCTCTTTGGCT 1121 TCATGGGTTTTTCTGCTTCCTGCCCCCACCCCCACATGTGCAATCCTCAAGATTTGTCCTGATTCTATTTCCTGGCACCT 1201 CCCTGCCTGTCCTTGGGGATTCTACTTCTTCCTGTGTGGGAGCCCATAGCTGTTGTCTAACAGGTAAGAAATGAAATTGA 1281 ACTATTGACTGGGCCCCAGAAATCCATAAAATGGCTGCAGACAGTTGTTTCTGTGTCCTGTTCTACCCCCACTCCAGTAC 1361 ATAACTACTATGTACTGTGTAGAGCCATTCTATATGCTGAATGTTCTGCTGTTGCAAACTTGCCAGGGTATTAGCCAGTG 1441 TTTGTGCCAAGCAGTTTTCTGGGACAACAGAATGACTCAGACCAAGATGGATAGGATGGTTAGGGCTTTGCTTCTTGCTG 1521 TTTTTCTTTGAAGCTAGTTCATTGTCCTGCAGGTCCCTTCATCTTCCATACCTAGCCCACTCTTTTAGCCCTTACCTTAA 1601 ATCTCTCAGATAAGTTGGTTCACAAAGAATGTTAAGTACTGAATCATGTGTGACTGAGACCAGAGATGGCAAATGAATGG 1681 CACACCATTTCTCCTTCTCCTGCCCCAGGGCAGGTACCACTGATCTGCATCAGAGTTGCCTGCTATTCTCTGGTGTATCC 1761 TTCACATCTAGGTGCCCTCAAGCAGCTGTGTGAGTGTTGAGATCTCTGCCATCTCTGGCTGAGATACTGCTGTCCTGTGA 1841 AGTGTTTCCCATGACCTTTTTCTTCCCCTTTGAATCCCTCTGTCTGGAGTAGTCCTTGCCTCTTCCTGCTCCAGTAGGGC 1921 CTTTTCCCTACCCCAGCCCCTGTGCCAGGCTAAGCTGGTACAAGAGCTGCCAACCTCACAGAGTGTTTGCTAGGCGAGAG 2001 AGGTGCAGGGAAGAGGCAGAGGTATGCACCTTCCCCCTTGAAGAGAGGGGAAAGGCCTACAGTGGCCCACATAATTGCCT 2081 GACTCACACTTCAGCTACCTCTTAATGCCTGTGGAGGGACTGGAGCTGCTGGATCCCAGTGTGGTGGTGTAGGAGGCCAC 2161 AGTGAGCAGGTGGCCCCAGCTGGGTTTCCCAGGTCAGGAATGTGGGCCCCAGGCAAGGTGCAGCCTTTGCTCACAGCTCC 2241 ATCCATGTCTAGACCTTCAGGCCAGTCTGCAGATGAGGTTCCCTACCTTTTTCTTCTCTTCATTGACCAAATCAACCAAT 2321 CACTACAGCTGCTCTGCTTCTGCTTTCCAAAGTAGCCCAGGTCCTGGGCCAGATGCAGGGGAGGTGCCTATCCATGAGTG 2401 AAGGCCAGTGTCTTCCTCACCTGGGTGGGTCCCACACTTGTGACCTCAGTTTTAGGACCAAGATCTGTGTTGGTTTCTTA 2481 GATTGCTAGCTTTTCCTCCAGGGGACCACAGCAGGTGAAGCTCAAGAGCGCATGGCTCTGCTAATAGTAAATTGTTTTCA 2561 GGGCCTTGTCCAGCTGAGAGCTTCATGTCCACCAGATTCTGAGAGGTGTCAGCAGCACTTTTTTTTTTTATTTGTTGTTT 2641 GTTTTCCATGAGGTTATCGGACCATGGGCTGAGCTCAGGCACTTTCTGTAGGAGACTGTTATTTCTGTAAAGATGGTTAT 2721 TTAACCCTCCTCCACCCCATCACGGTGGCCCTGAGGGCTGACCCGGAGGCCAGTGGAGCTGCCTGGTGTCCACGGGGGAG 2801 GGCCAAGGCCTGCTGAGCTGATTCTCCAGCTGCTGCCCCAGCCTTTCCGCCTTGCACAGCACAGAGGTGGTCACCCCAGG 2881 GACAGCCAGGCACCTGCTCCTCTTGCCCTTCCTGGGGGAAGGGAGCTGCCTTCTGTCCCTGTAACTGCTTTCCTTATGGC 2961 CCAGCCCGGCCACTCAGACTTGTTTGAAGCTGCACTGGCAGCTTTTTTGTCTCCTTTGGGTATTCACAACAGCCAGGGAC 3041 TTGATTTTGATGTATTTTAAACCACATTAAATAAAGAGTCTGTTGCCTTAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA 3121 AAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 200081.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714645. RNA binding protein: AGO2. Condition:completeT1
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM4903829 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Human neurons / CTLTD_shCTL_a |
Location of target site | NM_175852 | 3UTR | CUCACCUGGGUGGGU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161238 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM4903831 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Human neurons / 124TD_shELAVL3_a |
Location of target site | NM_175852 | 3UTR | CUCACCUGGGUGGGU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161238 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM4903833 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / CTL_TD_21_a |
Location of target site | NM_175852 | 3UTR | UUCAUGGGUUUUUCUGCUUCCUGCCCCCACCCCCACAUGUGCAAUCCUCAAGAUUUGUCCUGAUUCUAUUUCCUGGCACCUCC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM4903837 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_b |
Location of target site | NM_175852 | 3UTR | CACAUGUGCAAUCCUCAAGAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 5 for dataset GSM4903838 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | Dermal fibroblasts / 124_TD_21_c |
Location of target site | NM_175852 | 3UTR | CUGCCUCUUUGGCUUCAUGGGUUUUUCUGCUUCCUGCCCCCACCCCCACAUGUGCAAUCCUCAAGAUUUGUCCUGAUUCUAUUUCCUGGCACCUCCCUGC |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE161239 |
CLIP-seq Viewer | Link |
CLIP-seq Support 6 for dataset GSM714645 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / completeT1, repB |
Location of target site | ENST00000373610.3 | 3UTR | CCCCCACCCCCACAUGUGCAAUCCUCAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 7 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000373610.3 | 3UTR | CUUCCUGCCCCCACCCCCACAUGUGCAAUCCUCAAG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
111 hsa-miR-3915 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT059544 | PIP5K1A | phosphatidylinositol-4-phosphate 5-kinase type 1 alpha | 2 | 2 | ||||||||
MIRT081703 | ZNF507 | zinc finger protein 507 | 2 | 2 | ||||||||
MIRT083311 | ZCCHC3 | zinc finger CCHC-type containing 3 | 2 | 6 | ||||||||
MIRT119046 | SFT2D3 | SFT2 domain containing 3 | 2 | 2 | ||||||||
MIRT189381 | TXLNA | taxilin alpha | 2 | 4 | ||||||||
MIRT195895 | C16ORF72 | chromosome 16 open reading frame 72 | 2 | 6 | ||||||||
MIRT223807 | OXR1 | oxidation resistance 1 | 2 | 2 | ||||||||
MIRT292954 | ZNF146 | zinc finger protein 146 | 2 | 4 | ||||||||
MIRT293949 | RPL13A | ribosomal protein L13a | 2 | 6 | ||||||||
MIRT300900 | KREMEN1 | kringle containing transmembrane protein 1 | 2 | 2 | ||||||||
MIRT339332 | SESN2 | sestrin 2 | 2 | 2 | ||||||||
MIRT349304 | ZNF317 | zinc finger protein 317 | 2 | 2 | ||||||||
MIRT364736 | TOR1B | torsin family 1 member B | 2 | 2 | ||||||||
MIRT366233 | VMA21 | VMA21, vacuolar ATPase assembly factor | 2 | 2 | ||||||||
MIRT384605 | CLIC4 | chloride intracellular channel 4 | 2 | 2 | ||||||||
MIRT401745 | HLA-DRA | major histocompatibility complex, class II, DR alpha | 2 | 2 | ||||||||
MIRT443169 | UBL3 | ubiquitin like 3 | 2 | 2 | ||||||||
MIRT444215 | METTL12 | methyltransferase like 12 | 2 | 2 | ||||||||
MIRT444375 | SH3TC2 | SH3 domain and tetratricopeptide repeats 2 | 2 | 2 | ||||||||
MIRT445340 | TCEANC | transcription elongation factor A N-terminal and central domain containing | 2 | 2 | ||||||||
MIRT445474 | KDM6A | lysine demethylase 6A | 2 | 2 | ||||||||
MIRT445598 | CAMK2N1 | calcium/calmodulin dependent protein kinase II inhibitor 1 | 2 | 2 | ||||||||
MIRT445630 | TMEM50A | transmembrane protein 50A | 2 | 2 | ||||||||
MIRT446012 | VNN1 | vanin 1 | 2 | 2 | ||||||||
MIRT446115 | ASTN1 | astrotactin 1 | 2 | 2 | ||||||||
MIRT446248 | ELP2 | elongator acetyltransferase complex subunit 2 | 2 | 2 | ||||||||
MIRT446382 | SYNCRIP | synaptotagmin binding cytoplasmic RNA interacting protein | 2 | 2 | ||||||||
MIRT446940 | ZMAT3 | zinc finger matrin-type 3 | 2 | 2 | ||||||||
MIRT446967 | SLCO4C1 | solute carrier organic anion transporter family member 4C1 | 2 | 2 | ||||||||
MIRT447178 | PGRMC2 | progesterone receptor membrane component 2 | 2 | 2 | ||||||||
MIRT447209 | APBB2 | amyloid beta precursor protein binding family B member 2 | 2 | 2 | ||||||||
MIRT447237 | IHH | indian hedgehog | 2 | 2 | ||||||||
MIRT447807 | EMX1 | empty spiracles homeobox 1 | 2 | 2 | ||||||||
MIRT447853 | RRP8 | ribosomal RNA processing 8 | 2 | 4 | ||||||||
MIRT448054 | MMP15 | matrix metallopeptidase 15 | 2 | 2 | ||||||||
MIRT448094 | RASD2 | RASD family member 2 | 2 | 2 | ||||||||
MIRT448704 | KLHL11 | kelch like family member 11 | 2 | 2 | ||||||||
MIRT448851 | FEM1C | fem-1 homolog C | 2 | 2 | ||||||||
MIRT449488 | ZBTB4 | zinc finger and BTB domain containing 4 | 2 | 2 | ||||||||
MIRT449785 | C1orf109 | chromosome 1 open reading frame 109 | 2 | 2 | ||||||||
MIRT450774 | PDE3A | phosphodiesterase 3A | 2 | 2 | ||||||||
MIRT451124 | ZNF99 | zinc finger protein 99 | 2 | 2 | ||||||||
MIRT452676 | GPR156 | G protein-coupled receptor 156 | 2 | 2 | ||||||||
MIRT452888 | PSD4 | pleckstrin and Sec7 domain containing 4 | 2 | 2 | ||||||||
MIRT453188 | ACSF2 | acyl-CoA synthetase family member 2 | 2 | 2 | ||||||||
MIRT453353 | ZNF3 | zinc finger protein 3 | 2 | 2 | ||||||||
MIRT454502 | ZFYVE27 | zinc finger FYVE-type containing 27 | 2 | 2 | ||||||||
MIRT454629 | FAM83H | family with sequence similarity 83 member H | 2 | 2 | ||||||||
MIRT455183 | AGTRAP | angiotensin II receptor associated protein | 2 | 2 | ||||||||
MIRT458204 | FOXL2 | forkhead box L2 | 2 | 2 | ||||||||
MIRT458723 | CES2 | carboxylesterase 2 | 2 | 2 | ||||||||
MIRT458942 | SAMD4B | sterile alpha motif domain containing 4B | 2 | 2 | ||||||||
MIRT460304 | FLCN | folliculin | 2 | 2 | ||||||||
MIRT460989 | SYT7 | synaptotagmin 7 | 2 | 2 | ||||||||
MIRT461697 | ZNF426 | zinc finger protein 426 | 2 | 2 | ||||||||
MIRT461903 | NECAB3 | N-terminal EF-hand calcium binding protein 3 | 2 | 2 | ||||||||
MIRT462193 | NDUFS1 | NADH:ubiquinone oxidoreductase core subunit S1 | 2 | 2 | ||||||||
MIRT462290 | PPM1H | protein phosphatase, Mg2+/Mn2+ dependent 1H | 2 | 2 | ||||||||
MIRT463795 | XPOT | exportin for tRNA | 2 | 2 | ||||||||
MIRT464649 | UBE2V1 | ubiquitin conjugating enzyme E2 V1 | 2 | 4 | ||||||||
MIRT465911 | TMEM189-UBE2V1 | TMEM189-UBE2V1 readthrough | 2 | 4 | ||||||||
MIRT465992 | TMEM189 | transmembrane protein 189 | 2 | 4 | ||||||||
MIRT466302 | TIMM22 | translocase of inner mitochondrial membrane 22 | 2 | 2 | ||||||||
MIRT466575 | TBC1D2B | TBC1 domain family member 2B | 2 | 2 | ||||||||
MIRT470558 | POU2F1 | POU class 2 homeobox 1 | 2 | 2 | ||||||||
MIRT471333 | PERP | PERP, TP53 apoptosis effector | 2 | 2 | ||||||||
MIRT471659 | PALM2 | paralemmin 2 | 2 | 2 | ||||||||
MIRT472363 | TSPAN1 | tetraspanin 1 | 2 | 2 | ||||||||
MIRT473468 | MCFD2 | multiple coagulation factor deficiency 2 | 2 | 2 | ||||||||
MIRT474702 | KIF3A | kinesin family member 3A | 2 | 2 | ||||||||
MIRT476067 | GRIN2A | glutamate ionotropic receptor NMDA type subunit 2A | 2 | 2 | ||||||||
MIRT476077 | GRB2 | growth factor receptor bound protein 2 | 2 | 2 | ||||||||
MIRT476423 | GBA2 | glucosylceramidase beta 2 | 2 | 2 | ||||||||
MIRT476463 | GATAD2B | GATA zinc finger domain containing 2B | 2 | 2 | ||||||||
MIRT477877 | DYNLL2 | dynein light chain LC8-type 2 | 2 | 2 | ||||||||
MIRT478240 | DDX3X | DEAD-box helicase 3, X-linked | 2 | 4 | ||||||||
MIRT479460 | CDK6 | cyclin dependent kinase 6 | 2 | 2 | ||||||||
MIRT481030 | BAZ2A | bromodomain adjacent to zinc finger domain 2A | 2 | 2 | ||||||||
MIRT491496 | HLA-DOA | major histocompatibility complex, class II, DO alpha | 2 | 2 | ||||||||
MIRT497585 | SLC23A1 | solute carrier family 23 member 1 | 2 | 2 | ||||||||
MIRT498542 | TMEM30B | transmembrane protein 30B | 2 | 2 | ||||||||
MIRT499263 | NBPF11 | NBPF member 11 | 2 | 2 | ||||||||
MIRT504698 | ZNF117 | zinc finger protein 117 | 2 | 2 | ||||||||
MIRT511288 | KLHL15 | kelch like family member 15 | 2 | 4 | ||||||||
MIRT523121 | HSP90B1 | heat shock protein 90 beta family member 1 | 2 | 4 | ||||||||
MIRT529601 | H1F0 | H1 histone family member 0 | 2 | 2 | ||||||||
MIRT533481 | TRIM71 | tripartite motif containing 71 | 2 | 2 | ||||||||
MIRT535571 | NUP37 | nucleoporin 37 | 2 | 4 | ||||||||
MIRT537869 | EDA2R | ectodysplasin A2 receptor | 2 | 2 | ||||||||
MIRT538010 | DNAJC10 | DnaJ heat shock protein family (Hsp40) member C10 | 2 | 2 | ||||||||
MIRT552681 | YWHAZ | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta | 2 | 4 | ||||||||
MIRT554986 | RAB39B | RAB39B, member RAS oncogene family | 2 | 2 | ||||||||
MIRT556659 | KMT2D | lysine methyltransferase 2D | 2 | 4 | ||||||||
MIRT557437 | GTPBP2 | GTP binding protein 2 | 2 | 2 | ||||||||
MIRT560813 | CRTAP | cartilage associated protein | 2 | 2 | ||||||||
MIRT562115 | IGFBP5 | insulin like growth factor binding protein 5 | 2 | 2 | ||||||||
MIRT563103 | IFRD2 | interferon related developmental regulator 2 | 2 | 2 | ||||||||
MIRT574199 | LMNB1 | lamin B1 | 2 | 2 | ||||||||
MIRT623920 | FMNL3 | formin like 3 | 2 | 2 | ||||||||
MIRT626551 | NMNAT2 | nicotinamide nucleotide adenylyltransferase 2 | 2 | 2 | ||||||||
MIRT645458 | ANKS6 | ankyrin repeat and sterile alpha motif domain containing 6 | 2 | 2 | ||||||||
MIRT649082 | CACNA1B | calcium voltage-gated channel subunit alpha1 B | 2 | 2 | ||||||||
MIRT659477 | CLDN1 | claudin 1 | 2 | 2 | ||||||||
MIRT667950 | HMGCS1 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 | 2 | 2 | ||||||||
MIRT701981 | MIER3 | MIER family member 3 | 2 | 2 | ||||||||
MIRT708694 | TFDP2 | transcription factor Dp-2 | 2 | 2 | ||||||||
MIRT709649 | DFFB | DNA fragmentation factor subunit beta | 2 | 2 | ||||||||
MIRT710090 | FAM229B | family with sequence similarity 229 member B | 2 | 2 | ||||||||
MIRT718396 | ALDH1A3 | aldehyde dehydrogenase 1 family member A3 | 2 | 2 | ||||||||
MIRT724972 | TNS1 | tensin 1 | 2 | 2 | ||||||||
MIRT756050 | HRH4 | histamine receptor H4 | 2 | 1 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|